Revoche e sospensioni, ritiri di lotti, farmaci carenti, note di sicurezza, rimborsabilità e nuovi medicinali — ogni giorno, automaticamente. Ultimo aggiornamento: 13/10/2026 08:15.
n. EU/1/12/789 · autorizzato il 28/09/2012 · Enurev Breezhaler is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients… · Novartis Europharm Limited · glycopyrronium bromide · ATC R03BB06
n. EU/1/26/2047 · Vislyfa is indicated in adults for:
• The treatment of neovascular (wet) age-related macular degeneration (AM… · Lupin Europe GmbH · ranibizumab · ATC S01LA04
n. EU/1/26/2042 · Vijoice is indicated for the treatment of adult and paediatric patients aged 2 years and older with severe or … · Novartis Europharm Limited · alpelisib · ATC L01EM03
n. EU/1/26/2040 · Jascayd is indicated for the treatment of adult patients with Idiopathic Pulmonary Fibrosis (IPF).
Jascayd is… · Boehringer Ingelheim International GmbH · nerandomilast · ATC L04AA61
n. EU/1/26/2044 · Boey is indicated for the temporary improvement in the appearance of moderate to severe lines between the eyeb… · AbbVie Limited · trenibotulinumtoxinE · ATC Pending
n. EU/1/26/2036 · Adults
Ablymico is indicated as an adjunct to a reduced-calorie diet and increased physical activity for we… · STADA Arzneimittel AG · Liraglutide · ATC A10BJ02
Lekoskop